Financial statements Neuroexpander

Balance sheet of Neuroexpander

Company age:
Age:
15 y. 9 m. 8 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of NEUROEXPANDER

Year
2022
2023
Total assets 1 552 126,59 1 538 285,87
A. Fixed assets 443 970,49 415 282,99
B. Current assets 1 108 156,10 1 123 002,88
C. Share capital contributions (basic funds) 0,00 0,00
D. Own shares (stocks) 0,00 0,00
Total liabilities 1 552 126,59 1 538 285,87
A. Equity 1 137 268,09 1 102 193,12
B. Liabilities and provisions for liabilities 414 858,50 436 092,75
I. Long-term liabilities 0,00 0,00
II. Short-term liabilities 333 726,01 354 960,26
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.